115 related articles for article (PubMed ID: 24090307)
21. Capecitabine and radiation therapy for advanced gastrointestinal malignancies.
Rich T
Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):27-30. PubMed ID: 12520637
[TBL] [Abstract][Full Text] [Related]
22. Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors.
Petrioli R; Pascucci A; Francini E; Marsili S; Fiaschi AI; Civitelli S; Tanzini G; Battistelli S; Lorenzi M; Roviello F; Francini G;
Anticancer Drugs; 2008 Jan; 19(1):91-6. PubMed ID: 18043134
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
Shah SR; Martin R; Dowell JE; Ussery SM
Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
[TBL] [Abstract][Full Text] [Related]
24. How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate.
Szetela AB; Gibson DE
Am J Nurs; 2007 Dec; 107(12):40-8; quiz 48-9. PubMed ID: 18049060
[TBL] [Abstract][Full Text] [Related]
25. The use of capecitabine in the combined-modality therapy for rectal cancer.
Liauw SL; Minsky BD
Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068
[TBL] [Abstract][Full Text] [Related]
26. Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma?
Yoney A; Isikli L
Asian Pac J Cancer Prev; 2013; 14(9):5127-31. PubMed ID: 24175788
[TBL] [Abstract][Full Text] [Related]
27. Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe.
Ou SH; Holcombe RF
Drugs; 2007; 67(4):611-2. PubMed ID: 17352521
[No Abstract] [Full Text] [Related]
28. Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
Norman G; Rice S; Spackman E; Stirk L; Danso-Appiah A; Suh D; Palmer S; Eastwood A
Health Technol Assess; 2011 May; 15 Suppl 1():33-42. PubMed ID: 21609651
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic evaluation of capecitabine in breast cancer.
Daniele G; Gallo M; Piccirillo MC; Giordano P; D'Alessio A; Del Giudice A; La Porta ML; Perrone F; Normanno N; De Luca A
Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):225-35. PubMed ID: 23301520
[TBL] [Abstract][Full Text] [Related]
30. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
[TBL] [Abstract][Full Text] [Related]
31. Capecitabine in the treatment of advanced gastric cancer.
Lee JL; Kang YK
Future Oncol; 2008 Apr; 4(2):179-98. PubMed ID: 18407732
[TBL] [Abstract][Full Text] [Related]
32. Capecitabine in the treatment of colorectal cancer.
Kelly C; Cassidy J
Expert Rev Anticancer Ther; 2007 Jun; 7(6):803-10. PubMed ID: 17555390
[TBL] [Abstract][Full Text] [Related]
33. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
Ben-Josef E
Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
[TBL] [Abstract][Full Text] [Related]
34. An evolving role for oral fluoropyrimidine drugs.
Diasio RB
J Clin Oncol; 2002 Feb; 20(4):894-6. PubMed ID: 11844808
[No Abstract] [Full Text] [Related]
35. Capecitabine as adjuvant treatment for stage III colon cancer.
Twelves C; Wong A; Nowacki MP; Abt M; Burris H; Carrato A; Cassidy J; Cervantes A; Fagerberg J; Georgoulias V; Husseini F; Jodrell D; Koralewski P; Kröning H; Maroun J; Marschner N; McKendrick J; Pawlicki M; Rosso R; Schüller J; Seitz JF; Stabuc B; Tujakowski J; Van Hazel G; Zaluski J; Scheithauer W
N Engl J Med; 2005 Jun; 352(26):2696-704. PubMed ID: 15987918
[TBL] [Abstract][Full Text] [Related]
36. Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States.
Saif MW; Shi N; Zelt S
World J Gastroenterol; 2009 Sep; 15(35):4415-22. PubMed ID: 19764093
[TBL] [Abstract][Full Text] [Related]
37. A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas.
Lo SS; Khorana AA; Javle M; Simon S; Kiefer G; Rajasenan K; Wang H; Hantel A; Shayne M; Hwang J; Schmotzer A; Ramanathan RK
Oncology; 2010; 78(2):125-9. PubMed ID: 20389134
[TBL] [Abstract][Full Text] [Related]
38. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.
Jansen EP; Boot H; Saunders MP; Crosby TD; Dubbelman R; Bartelink H; Verheij M; Cats A
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1424-8. PubMed ID: 17689023
[TBL] [Abstract][Full Text] [Related]
39. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
Das P; Lin EH; Bhatia S; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Delclos ME; Krishnan S; Janjan NA; Crane CH
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1378-83. PubMed ID: 17056196
[TBL] [Abstract][Full Text] [Related]
40. COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas.
Rich TA; Shepard R
Am J Clin Oncol; 2003 Aug; 26(4):S110-3. PubMed ID: 12902867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]